Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report

Ann Intern Med. 2016 Oct 18;165(8):607-608. doi: 10.7326/L16-0037.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / drug therapy*
  • Male
  • Nivolumab
  • Remission Induction
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Nivolumab